{"protocolSection":{"identificationModule":{"nctId":"NCT05833932","orgStudyIdInfo":{"id":"2021XS-001-05"},"organization":{"fullName":"Dongzhimen Hospital, Beijing","class":"OTHER"},"briefTitle":"Suhexiang Pill for Acute Ischemic Stroke: A Registry Study","officialTitle":"Suhexiang Pill for Acute Ischemic Stroke: A Prospective Registry Study of Real-world Data","acronym":"SUNRISE"},"statusModule":{"statusVerifiedDate":"2023-04","overallStatus":"NOT_YET_RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2023-05-01","type":"ESTIMATED"},"primaryCompletionDateStruct":{"date":"2024-12-31","type":"ESTIMATED"},"completionDateStruct":{"date":"2024-12-31","type":"ESTIMATED"},"studyFirstSubmitDate":"2023-03-24","studyFirstSubmitQcDate":"2023-04-18","studyFirstPostDateStruct":{"date":"2023-04-27","type":"ACTUAL"},"lastUpdateSubmitDate":"2023-04-18","lastUpdatePostDateStruct":{"date":"2023-04-27","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"PRINCIPAL_INVESTIGATOR","investigatorFullName":"Ying Gao","investigatorTitle":"Professor","investigatorAffiliation":"Dongzhimen Hospital, Beijing"},"leadSponsor":{"name":"Dongzhimen Hospital, Beijing","class":"OTHER"}},"oversightModule":{"oversightHasDmc":false,"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"The primary purpose of this study is to investigate the effectiveness and safety of the Suhexiang Pill for patients with acute ischemic stroke in real-world settings.","detailedDescription":"Suhexiang Pill, a traditional Chinese patent medicine, is widely used in China for acute stroke. However, there is a lack of evidence of its efficacy and safety for acute ischemic stroke in real-world setting. This registry study will recruit 1000 patients who receive Suhexiang Pill treatment after acute ischemic stroke."},"conditionsModule":{"conditions":["Ischemic Stroke"],"keywords":["acute ischemic stroke","traditional Chinese medicine","registry study"]},"designModule":{"studyType":"OBSERVATIONAL","patientRegistry":true,"targetDuration":"1 Year","designInfo":{"observationalModel":"COHORT","timePerspective":"PROSPECTIVE"},"enrollmentInfo":{"count":1000,"type":"ESTIMATED"}},"armsInterventionsModule":{"interventions":[{"type":"DRUG","name":"Suhexiang Pill","description":"Suhexiang Pill is an approved traditional Chinese patent medicine."}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Proportion of patients independent","description":"Proportion of patients independent is defined as the modified Rankin Scale score of 0, 1, or 2.","timeFrame":"90 days"}],"secondaryOutcomes":[{"measure":"National Institute of Health Stroke Scale","description":"The National Institute of Health Stroke Scale (NIHSS) ranges from 0 to 42, with higher scores indicating more severe neurological deficits.","timeFrame":"The change from baseline to day 10 or discharge."},{"measure":"Glasgow Coma Scale","description":"The Glasgow Coma Scale (GCS) is used to describe the extent of impaired consciousness in all types of acute medical and trauma patients, ranging from 0 to 15, with lower scores indicating more severe impaired consciousness.","timeFrame":"The change from baseline to day 10 or discharge."},{"measure":"Patient reported outcome","description":"The patient reported outcome (PRO) scale of stroke consists of four dimensions including the influence on physical, emotional, and social functioning, as well as the overall satisfaction with treatment.","timeFrame":"At day 10 or discharge."}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Acute ischemic stroke within 7 days of symptom onset.\n* Age â‰¥ 18\n* Patient who has received Suhexiang Pill treatment\n* Patient or legally authorized representative has signed informed consent.\n\nExclusion Criteria:\n\n* Be allergic to Suhexiang Pill\n* Known to be pregnant or breastfeeding.\n* With conditions that render outcomes or follow-up unlikely to be assessed.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"],"studyPopulation":"Patients diagnosed with Acute ischemic stroke.","samplingMethod":"NON_PROBABILITY_SAMPLE"},"contactsLocationsModule":{"locations":[{"facility":"Dongzhimen Hospital","city":"Beijing","state":"Beijing","zip":"100700","country":"China","contacts":[{"name":"Xinxing Lai, M.D.","role":"CONTACT","phone":"15901111280","email":"new-star@163.com"}],"geoPoint":{"lat":39.9075,"lon":116.39723}}]},"ipdSharingStatementModule":{"ipdSharing":"UNDECIDED"}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"},{"id":"D000083242","term":"Ischemic Stroke"},{"id":"D000002544","term":"Cerebral Infarction"},{"id":"D000007511","term":"Ischemia"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000010335","term":"Pathologic Processes"},{"id":"D000020520","term":"Brain Infarction"},{"id":"D000002545","term":"Brain Ischemia"},{"id":"D000007238","term":"Infarction"},{"id":"D000009336","term":"Necrosis"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M10233","name":"Ischemia","asFound":"Ischemic","relevance":"HIGH"},{"id":"M2401","name":"Ischemic Stroke","asFound":"Ischemic Stroke","relevance":"HIGH"},{"id":"M9972","name":"Infarction","relevance":"LOW"},{"id":"M5483","name":"Cerebral Infarction","asFound":"Ischemic Stroke","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"M21995","name":"Brain Infarction","relevance":"LOW"},{"id":"M5484","name":"Brain Ischemia","relevance":"LOW"},{"id":"M11974","name":"Necrosis","relevance":"LOW"},{"id":"T170","name":"Acute Graft Versus Host Disease","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"Rare","name":"Rare Diseases"}]}},"hasResults":false}